Advancing innovative precision therapeutics for debilitating and rare diseases
View Top Employees from Quince TherapeuticsWebsite | http://www.quincetx.com |
Ticker | CRTX |
Revenue | $7 million |
Funding | $7.6 million |
Employees | 23 (22 on RocketReach) |
Founded | 2012 |
Address | 601 Gateway Blvd Suite 1250, South San Francisco, California 94080, US |
Phone | (415) 910-5717 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Industry | Education, Organizations, Biotechnology Research, Biotechnology, Alzheimer's, Science and Engineering, Neuroscience, Medical, Neurodegenerative Disease, Health Care, Pharmaceutical |
Web Rank | 3 Million |
Keywords | Cortexyme, Corexyme, Casey Lynch Paper, Cortexyme Inc Study Of Cor388, Cortexyme Inc |
Competitors | Affectis Pharmaceuticals, Brickell Biotech, Inc., Helix Biopharma Corp (HBPCF), Rexahn Pharmaceuticals, Soligenix, Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541711 Companies, NAICS Code 5417 Companies |
Looking for a particular Quince Therapeutics employee's phone or email?
The Quince Therapeutics annual revenue was $7 million in 2024.
Charles Ryan is the President of Quince Therapeutics.
22 people are employed at Quince Therapeutics.
Quince Therapeutics is based in South San Francisco, California.
The NAICS codes for Quince Therapeutics are [54171, 54, 541, 541711, 5417].
The SIC codes for Quince Therapeutics are [87, 873].